QM Diagnostics

QM Diagnostics is a leading contract research organization specializing in health monitoring services for laboratory animals used in biomedical research. Based in the Netherlands, the company provides comprehensive diagnostic testing, including serology, microbiology, and molecular biology, to ensure the health and standardized quality of research models. Originally a spin-off from the Radboud University Medical Center, it was acquired by Charles River Laboratories in 2016 to bolster their global diagnostic capabilities. The company serves academic institutions, pharmaceutical companies, and biotechnology firms globally, helping them maintain pathogen-free environments for their animal facilities. Their service portfolio includes advanced technologies such as Multiplex Fluorescent Immunoassay (MFI) and MALDI-TOF for rapid and accurate pathogen detection.